CYP3A4 and coronary artery disorder: No contraindication in those with coronary artery disease, cerebrovascular accident, or vascular diseaseAvoid with strong (medium for some) CYP3A4 inducers or inhibitors; dose limitations with moderate inhibitorsCan be taken on the same day with triptans or ergots